17th World ADC San Diego Leaderboard
  • Thursday, May 14, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Obesity & Weight Loss Drug Development Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 332

Author

Pharma Journalist 8791 posts 0 comments

Provectus Algae Expands into New Large-Scale Microalgae Biomanufacturing Facility

Aug 25, 2021
Provectus Algae (Provectus), an Australian biotechnology platform company specialising in the biomanufacturing of high-value compounds for a wide array of industries using microalgae,…
Read More...

FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals

Aug 25, 2021
FSD Pharma Inc. a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, announces today it has…
Read More...

Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough…

Aug 25, 2021
Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target strategic collaboration and…
Read More...

FLEXcon Announces Global Launch of New PHARMcal Portfolio for Pharmaceutical Labeling

Aug 24, 2021
FLEXcon Company, Inc., an innovator in adhesive coating and laminating, today announced the relaunch of its FLEXcon PHARMcal line of track and trace solutions featuring engineered films…
Read More...

European Commission Approves RINVOQ (upadacitinib) as First JAK Inhibitor in the European Union for…

Aug 24, 2021
AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib), an oral, selective and reversible JAK inhibitor, for the treatment of moderate to severe atopic dermatitis…
Read More...

Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination…

Aug 24, 2021
Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical need and large public health burden, announced that its…
Read More...

InDex Pharmaceuticals receives FDA clearance to start the phase III study CONCLUDE with cobitolimod

Aug 24, 2021
InDex Pharmaceuticals Holding AB (publ) announced that the U.S. Food and Drug Administration (FDA) has given clearance to start the phase III clinical study CONCLUDE in the United…
Read More...

Pfizer to Acquire Trillium Therapeutics Inc.

Aug 24, 2021
Pfizer Inc. and Trillium Therapeutics Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage…
Read More...

Pfizer-BioNTech COVID-19 Vaccine COMIRNATY Receives Full U.S. FDA Approval for Individuals 16 Years…

Aug 23, 2021
Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY (COVID-19 Vaccine, mRNA) to prevent…
Read More...

FDA Accepts for Priority Review Bristol Myers Squibb’s Application for Orencia (abatacept) for the…

Aug 23, 2021
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Orencia (abatacept) for the…
Read More...
Prev Next
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
5th World ADC Summit South Korea
Extrahepatic Lipid-Based Nanoparticles Delivery Summit
World TPD & Induced Proximity Summit South Korea
Investigative & Preclinical Toxicology Summit 2026
LEAP HR: Life Sciences West
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
R&D Procurement & Sourcing in Pharma Summit
In Vivo Cell Engineering & Gene Editing Summit
PFS & Injectable Drug Delivery West Coast
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
World Bispecific & T-Cell Engager Summit South Korea
TCR-Based Therapies Summit
Nasal Formulation & Delivery Summit
ALS Drug Development Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC San Diego Unveils Preliminary Agenda for 17th Annual Meeting
  • GSK Partners With Sino Biopharmaceutical on Hepatitis B Drug
  • EU Approves Sotyktu for Psoriatic Arthritis
  • FDA Seeks Public Input on Drug Repurposing Efforts
  • FDA Approves BIZENGRI for NRG1+ Cholangiocarcinoma

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

Turning Biophysical Data into Confident Drug Discovery…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.